Skip to main content

Table 1 Sex and race/ethnic representation in the original studies supporting the 2021 Surviving Sepsis Campaign guidelines

From: Patient diversity and author representation in clinical studies supporting the Surviving Sepsis Campaign guidelines for management of sepsis and septic shock 2021: a systematic review of citations

Recommendations

Studies

(n)

Sample size (n)

Males1

n (%)

Reported race2

n (%)

White3

n (%)

Black3

n (%)

Hispanic3

n (%)

Others3

n (%)

Screening & Early Treatment

30

2,741,771

1,300,889

(48)

5

(17)

793,221

(68)

193,612

(17)

94,769

(9)

81,421

(7)

Infection

126

779,053

424,672

(61)

21

(17)

134,091

(73)

28,320

(16)

2,861

(12)

17,731

(10)

Hemodynamic Management

47

68,939

37,531

(56)

10

(21)

32,623

(74)

3,508

(14)

3

(15)

4,049

(17)

Ventilation

41

28,683

13,732

(62)

6

(15)

2,178

(74)

390

(16)

205

(9)

57

(4)

Additional Therapies

36

232,790

123,081

(54)

5

(14)

1057

(77)

181

(19)

30

(5)

40

(4)

Long Term Outcomes/

Goals of Care

83

2,508,901

1,183,748

(47)

30

(36)

838,323

(71)

209,136

(17)

87,554

(8)

42,648

(4)

  1. 1Some studies may not have reported the sex; the proportion of males reflects the proportion from the studies that reported sex
  2. 2Refers to the number of studies that had race reported in the patient characteristics
  3. 3Refers to the proportion based on the studies that reported each of the listed race/ethnicity; total may not add up to 100% given that there is inconsistency in the race/ethnicity reported by each study
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us